Pharmacokinetics and in-situ absorption studies of a new anti-allergic compound 73/602 in rats

International Journal of Pharmaceutics

Volumn 197, Issue 1-2, 2000, Pages 213-220

  Paliwa, J K ^a   Dwivedi, A K ^b   Singh, S ^b   Gutpa, R C ^b  

^a RANBAXY RESEARCH LABORATORIES   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Absorption; Anti allergic; Compound 73 602; Pharmacokinetics

Indexed keywords

2,3 DIHYDRO 7 METHOXYPYRROLO[2,1 B]QUINAZOLIN 9(1H) ONE; 7 METHOXYDEOXYVASICINONE; ANTIALLERGIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG STRUCTURE; INTESTINE BLOOD FLOW; MALE; NONHUMAN; PH; PKA; PRIORITY JOURNAL; RAT; SMALL INTESTINE ABSORPTION; TRANSPORT KINETICS;

ADMINISTRATION, ORAL; ANIMALS; ANTI-ALLERGIC AGENTS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HYDROGEN-ION CONCENTRATION; INJECTIONS, INTRAVENOUS; INTESTINAL ABSORPTION; MALE; PHARMACEUTICAL SOLUTIONS; QUINAZOLINES; RATS; RATS, SPRAGUE-DAWLEY; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0034004428     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(00)00324-0     Document Type: Article

References (15)

1. Albert A., Serjeant E.P. Ionization constants of acids and bases: A laboratory manual. 1962;69-92 Methuen, London.
2. Arya, V.P., 1982. Drugs of Future 7, 549.
3. Bailer M. J. Pharmacokin. Biopharm. 8:1980;111-113.
4. Brogden R.N., Speight T.M., Avery G.S. Sodium cromoglycate (cromolyn sodium): a review of its mode of action, pharmacology, therapeutic efficacy and use. Drugs. 7:1974;164-282.
5. Devi G., Kapil R.S., Popli S.P. Potential CNS and CVS agents: synthesis based on vascinone. Ind. J. Chem. 14B:1976;354-356.
6. Diamond L., Doluisio J.T., Crouthamel W.G. Physiological factors affecting intestinal drug absorption. Eur. J. Pharmacol. 11:1970;111-114.
7. Doluisio J.T., Bilups N.F., Tukker J.J., Crommelin D.J.A. Drug absorption. I. an in-situ rat gut technique yielding realistic absorption rates. J. Pharm. Sci. 58:1969;1197-1198.
8. Gibaldi, M., Perrier, D., 1975. Drugs and Pharmaceutical Sciences In: Swarbric J. (Ed.), Monographs, vol. 1, Marcel Dekker, New York.
9. Gupta C.M., Bhaduri A.P., Khanna N.M. Biologically active quinazolones and related compounds. J. Sci. Ind. Res. 30:1971;101-106.
10. Lahiri P.K., Pradhan S.N. Pharmacological investigation of vasicinol - an alkaloid from Adhatoda vasica Nees. Ind. J. Exp. Biol. 2:1964;219-223.
11. Paliwal J.K., Grover P.K., Gupta R.C. Quantification of 2,3-dihydro-7-methoxypyrrolo-[2, I-b]-quinazolin-9 (IH)-one, new antiallergic agent by HPLC in serum. J. Chromatogr. B. 658:1994;198-201.
12. PCNONLIN Version 4.0, 1992, Professional Data analysis software SCI, Software, Lexington, KY, USA.
13. Seth R.K., Dwivedi A.K., Chaudhry M., Singh C., Sarin J.P.S. Analytical and shelf life studies of a new antiallergic compound 7-methoxy-deoxy vasicinone. Ind. J. Pharma. Sci. 52:1990;162-164.
14. Southon I.W., Buckingham J. Dictionary of Alkaloids. 1989;1112 Chapman and Hall, London.
15. Swintosky J.V., Pogonowska-wala E. The in-situ rat gut technique. Pharm. Ind. 3:1982;163-167.